Global Infertility Treatment Market 2018-2022
SKU ID : TNV-12294805 | Publishing Date : 18-Apr-2018 | No. of pages : 114
Detailed TOC of Global Infertility Treatment Market 2018-2022
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
• Comparison by application
• Global infertility treatment market by male infertility treatment
• Global infertility treatment market by female infertility treatment
• Market opportunity by application
PART 08: CUSTOMER LANDSCAPE
PART 09: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Infertility treatment market in Americas
• Infertility treatment market in EMEA
• Infertility treatment market in APAC
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
• Emergence of digital innovations
• Growing acceptance of same-sex marriages
• Growing online retail sales of drugs
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• AbbVie
• Cook Group
• Ferring
• Merck
• The Cooper Companies
• Vitrolife
PART 15: APPENDIX
• List of abbreviations
Exhibit 01: Related market: global healthcare market
Exhibit 02: Market characteristics
Exhibit 03: Market segments
Exhibit 04: Market definition - Inclusions and exclusions checklist
Exhibit 05: Market size 2017
Exhibit 06: Validation techniques employed for market sizing 2017
Exhibit 07: Global infertility treatment market – Market size and forecast 2017-2022 ($ bn)
Exhibit 08: Global infertility treatment market – Year over year growth 2018-2022 (%)
Exhibit 09: Five forces analysis 2017
Exhibit 10: Five forces analysis 2022
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2017
Exhibit 17: Global infertility treatment market by application – Market share 2017-2022 (%)
Exhibit 18: Comparison by application
Exhibit 19: Global infertility treatment market by male infertility treatment – Market size and forecast 2017-2022 ($ bn)
Exhibit 20: Global infertility treatment market by male infertility treatment – Year over year growth 2018-2022 (%)
Exhibit 21: Global infertility treatment market by female infertility treatment – Market size and forecast 2017-2022 ($ bn)
Exhibit 22: Global infertility treatment market by female infertility treatment – Year over year growth 2018-2022 (%)
Exhibit 23: Market opportunity by application
Exhibit 24: Customer landscape
Exhibit 25: Global infertility treatment market by region – Market share 2017-2022 (%)
Exhibit 26: Regional comparison
Exhibit 27: Infertility treatment market in Americas – Market size and forecast 2017-2022 ($ bn)
Exhibit 28: Infertility treatment market in Americas – Year over year growth 2018-2022 (%)
Exhibit 29: Top three countries in Americas
Exhibit 30: Infertility treatment market in EMEA – Market size and forecast 2017-2022 ($ bn)
Exhibit 31: Infertility treatment market in EMEA – Year over year growth 2018-2022 (%)
Exhibit 32: Top three countries in EMEA
Exhibit 33: Infertility treatment market in APAC – Market size and forecast 2017-2022 ($ bn)
Exhibit 34: Infertility treatment market in APAC – Year over year growth 2018-2022 (%)
Exhibit 35: Top three countries in APAC
Exhibit 36: Market opportunity
Exhibit 37: Cost breakdown of IVF by various stages in US
Exhibit 38: Top mobile applications improving infertility awareness
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: AbbVie: Vendor overview
Exhibit 45: AbbVie – Business segments
Exhibit 46: AbbVie – Organizational developments
Exhibit 47: AbbVie – Geographic focus
Exhibit 48: AbbVie – Segment focus
Exhibit 49: AbbVie – Key offerings
Exhibit 50: Cook Group: Vendor overview
Exhibit 51: Cook Group – Business segments
Exhibit 52: Cook Group – Organizational developments
Exhibit 53: Cook Group – Geographic focus
Exhibit 54: Cook Group – Segment focus
Exhibit 55: Cook Group – Key offerings
Exhibit 56: Ferring: Vendor overview
Exhibit 57: Ferring – Business segments
Exhibit 58: Ferring – Organizational developments
Exhibit 59: Ferring – Geographic focus
Exhibit 60: Ferring – Segment focus
Exhibit 61: Ferring – Key offerings
Exhibit 62: Merck: Vendor overview
Exhibit 63: Merck – Business segments
Exhibit 64: Merck – Organizational developments
Exhibit 65: Merck – Geographic focus
Exhibit 66: Merck – Segment focus
Exhibit 67: Merck – Key offerings
Exhibit 68: The Cooper Companies: Vendor overview
Exhibit 69: The Cooper Companies – Business segments
Exhibit 70: The Cooper Companies – Organizational developments
Exhibit 71: The Cooper Companies – Geographic focus
Exhibit 72: The Cooper Companies – Segment focus
Exhibit 73: The Cooper Companies – Key offerings
Exhibit 74: Vendor overview
Exhibit 75: Vitrolife – Business segments
Exhibit 76: Vitrolife – Organizational developments
Exhibit 77: Vitrolife – Geographic focus
Exhibit 78: Vitrolife – Segment focus
Exhibit 79: Vitrolife – Key offerings